BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Kostapanos MS, Elisaf MS. High density lipoproteins and type 2 diabetes: Emerging concepts in their relationship. World J Exp Med 2014; 4(1): 1-6 [PMID: 24977116 DOI: 10.5493/wjem.v4.i1.1]
URL: https://www.wjgnet.com/1007-9327/full/v4/i1/1.htm
Number Citing Articles
1
Shuwu Zhao, Yiming Li, Chen Su. Assessment of common risk factors of diabetes and chronic kidney disease: a Mendelian randomization studyFrontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1265719
2
Chia-Chun Wu, Yu-Hsuan Cheng, Kuo-Hsin Chen, Chiang-Ting Chien. Deep Sea Water-Dissolved Organic Matter Intake Improves Hyperlipidemia and Inhibits Thrombus Formation and Vascular Inflammation in High-Fat Diet HamstersLife 2022; 12(1): 82 doi: 10.3390/life12010082
3
Camelia S. Stancu, Mihaela G. Carnuta, Gabriela M. Sanda, Laura Toma, Mariana Deleanu, Loredan S. Niculescu, Shlomo Sasson, Maya Simionescu, Anca V. Sima. Hyperlipidemia‐induced hepatic and small intestine ER stress and decreased paraoxonase 1 expression and activity is associated with HDL dysfunction in Syrian hamstersMolecular Nutrition & Food Research 2015; 59(11): 2293 doi: 10.1002/mnfr.201500422
4
Manuel Alejandro Vargas-Vargas, Alfredo Saavedra-Molina, Mariana Gómez-Barroso, Donovan Peña-Montes, Christian Cortés-Rojo, Huerta Miguel, Xochitl Trujillo, Rocío Montoya-Pérez. Dietary Iron Restriction Improves Muscle Function, Dyslipidemia, and Decreased Muscle Oxidative Stress in Streptozotocin-Induced Diabetic RatsAntioxidants 2022; 11(4): 731 doi: 10.3390/antiox11040731
5
Niki Katsiki, Genovefa Kolovou, Pablo Perez-Martinez, Dimitri P. Mikhailidis. Dyslipidaemia in the elderly: to treat or not to treat?Expert Review of Clinical Pharmacology 2018; 11(3): 259 doi: 10.1080/17512433.2018.1425138
6
S. Kh. Mehdiyev, I. I. Mustafaev, M. N. Mamedov. Features of Cardiovascular Risk Factors, Target Organ Damage in Patients with Diabetes Mellitus Type 2 and Arterial HypertensionKardiologiia 2019; 59(9): 20 doi: 10.18087/cardio.2019.9.10271
7
Ravi Kant Upadhyay. Emerging Risk Biomarkers in Cardiovascular Diseases and DisordersJournal of Lipids 2015; 2015: 1 doi: 10.1155/2015/971453
8
Karzan SAEED, Tahir KAHRAMAN. Protective effect of Vaccinium myrtillus on Paraoxonase Activity, Some Biochemical Parameters and Pancreatic Functions in Diabetic RatsVan Sağlık Bilimleri Dergisi 2022; 15(2): 103 doi: 10.52976/vansaglik.810482
9
Carlos Aguiar, Eduardo Alegria, Riccardo C. Bonadonna, Alberico L. Catapano, Francesco Cosentino, Moses Elisaf, Michel Farnier, Jean Ferrières, Pasquale Perrone Filardi, Nicolae Hancu, Meral Kayikcioglu, Alberto Mello e Silva, Jesus Millan, Željko Reiner, Lale Tokgozoglu, Paul Valensi, Margus Viigimaa, Michal Vrablik, Alberto Zambon, José Luis Zamorano, Roberto Ferrari. A review of the evidence on reducing macrovascular risk in patients with atherogenic dyslipidaemia: A report from an expert consensus meeting on the role of fenofibrate–statin combination therapyAtherosclerosis Supplements 2015; 19: 1 doi: 10.1016/S1567-5688(15)30001-5
10
Niki Katsiki, Nikolaos Tentolouris, Dimitri P. Mikhailidis. Dyslipidaemia in type 2 diabetes mellitusCurrent Opinion in Cardiology 2017; 32(4): 422 doi: 10.1097/HCO.0000000000000407